Carlyle Group Inc [NASDAQ: CG] plunged by -$1.04 during the normal trading session on while it closed the day at $45.47. Carlyle Group Inc stock has also gained 9.57% of its value over the past 7 days. However, CG stock has inclined by 0.91% in
Carlyle Group Inc [NASDAQ: CG] gained 0.74% on the last trading session, reaching $39.56 price per share at the time. If compared to the average trading volume of 2.07M shares, CG reached a trading volume of 3863869 in the most recent trading day, which is
Carlyle Group Inc [NASDAQ: CG] stock went on an upward path that rose over 1.13% on Wednesday, amounting to a one-week price decrease of less than -5.81%. Over the last 12 months, CG stock rose by 33.15%. The one-year Carlyle Group Inc stock forecast points
Carlyle Group Inc [NASDAQ: CG] traded at a low on Wednesday, posting a -1.53 loss after which it closed the day’ session at $43.71. The results of the trading session contributed to over 3491172 shares changing hands. Over the past one week, the price volatility
Carlyle Group Inc [NASDAQ: CG] stock went on a downward path that fall over -1.50% on Thursday, amounting to a one-week price increase of more than 2.43%. Over the last 12 months, CG stock rose by 65.02%. The one-year Carlyle Group Inc stock forecast points
Carlyle Group Inc [NASDAQ: CG] plunged by -$3.83 during the normal trading session on while it closed the day at $40.97. Carlyle Group Inc stock has also loss -11.17% of its value over the past 7 days. However, CG stock has inclined by 2.37% in
Carlyle Group Inc [NASDAQ: CG] slipped around -0.95 points on Thursday, while shares priced at $43.68 at the close of the session, down -2.13%. Compared to the average trading volume of 2.31M shares, CG reached a trading volume of 2776111 in the most recent trading
Carlyle Group Inc [NASDAQ: CG] gained 0.21% on the last trading session, reaching $46.97 price per share at the time. The company report on April 1, 2024 at 8:30 AM that Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma
Copyright © 2024, Powered by Smart TechOne
